ESPR
Esperion Therapeutics Inc.
Latest News for ESPR
Esperion ( ($ESPR) ) has shared an update. On April 2, 2026, Esperion Therapeutics amended its existing credit agreement to add a $25 million term ......
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Passage Bio (PASG), Phreesia (PHR) and Esperion (ESPR). Passage B......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Esperion (ESPR – Research Report) and NovaBridge Bio......
Piper Sandler analyst David Amsellem reiterated a Buy rating on Esperion today and set a price target of $9.00. According to TipRanks, Amsellem is ......
News data is sourced from MarketXLS API and updated regularly.
Showing 4 of 4 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ESPR | $2.31 | -0.2% | 3.21M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Esperion Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW